SCHEMBL2804553

SCHEMBL2804553

Cc1cnc2c(S(=O)(=O)NC3CCc4c(cnc5[nH]ncc45)C3)cccc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
MCOLN3 Q8TDD5 1/20 0.39
SLC40A1 Q9NP59 6/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.35
SLC16A3 O15427 1/20 0.34
MEN1 O00255 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
RECQL P46063 1/20 0.34
KMT2A Q03164 1/20 0.34
HTR6 P50406 2/20 0.34
KDM4E B2RXH2 2/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
ACHE P22303 1/20 0.32
NPY1R P25929 1/20 0.32
NPY5R Q15761 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2807827 0.83 PAK1 (0.36) ALDH1A1LMNAKMT2ACA1CA2
SCHEMBL2803744 0.82 ALDH1A1 (0.37) ALDH1A1SLC40A1HTR6CA1CA2
SCHEMBL2805214 0.82 FBP1 (0.39) ALDH1A1LMNAHTR6
SCHEMBL2803283 0.82 L3MBTL1 (0.35) MEN1KMT2A
SCHEMBL2803951 0.82 BRD4 (0.39) MEN1KMT2A
SCHEMBL2802680 0.80 JAK2 (0.44) ALDH1A1LMNAMAPK1MEN1KMT2A
SCHEMBL2804229 0.80 ALDH1A1 (0.42) ALDH1A1LMNAMAPK1MEN1KMT2A
SCHEMBL2806444 0.80 SGK1 (0.47)
SCHEMBL2802818 0.80 SGK1 (0.40) ALDH1A1
SCHEMBL2803149 0.80 ALDH1A1 (0.47) ALDH1A1MEN1CYP3A4CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263610-B2 Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds ARQULE, INC. (US) 2012-09-11 US disclosed
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078427-A1 SUBSTITUTED PYRAZOLO [3, 4-B] PYRIDINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS NQO1, IDH3B, IDH1 ALDH1A1 460/4885LMNA 1591/4885MCOLN3 2222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.